• What we do
  • The People
  • About Us
  • Why Innovation Africa
  • Contact Us
Innovation AfricaCreating the Future Today
  • Feature Articles
  • Innovation
  • Agriculture
  • ICT
  • Technology
  • Entrepreneurship
  • Health
  • Store
  • Contact Us
Menu
  • Feature Articles
  • Innovation
  • Agriculture
  • ICT
  • Technology
  • Entrepreneurship
  • Health
  • Store
  • Contact Us
  • New whole plant therapy shows promise as an effective and economical treatment for malaria

    January 2, 2013 Editor 0

    Research by scientists at Worcester Polytechnic Institute and UMass published today in PLOS ONE may point the way toward a new model for malaria treatment that could also be a socioeconomic stimulus for developing nations

     

    Worcester, Mass. – In the worldwide battle to curtail malaria, one of the most prevalent and deadly infectious diseases of the developing world, drug after drug has fallen by the wayside as the malaria parasite has become resistant to it. Only artemisinin, derived from the sweet wormwood plant, Artemisia annua, remains as an effective treatment, but it is expensive to produce (particularly when combined with other antimalarial medications to make it less prone to resistance) and is frequently in short supply.

    A new study by scientists at Worcester Polytechnic Institute (WPI) and the University of Massachusetts has shown that the powdered dried leaves from theArtemisia annua plant may be a far more effective antimalarial treatment than purified artemisinin, delivering 40 times more artemisinin to the blood and reducing the level of parasite infection more completely in mice. The effectiveness of the whole plant, versus the purified drug, may be due, in part, to the presence in Artemisia annua leaves of other compounds, including flavonoids also known to have antimalarial abilities, which may create a combination therapy that works synergistically to combat the parasite and ward off resistance.

    These are some of the conclusions of a paper titled “Dried whole plantArtemisia annua as an antimalarial therapy,” published online today by the journal PLOS ONE .

    Using the dried whole plant, instead of purified artemisinin, could significantly lower the cost of treating malaria, since it would eliminate the need to extract the drug from the plant and purify it, and could greatly expand access to antimalarial therapy, according to Pamela Weathers, professor of biology and biotechnology at WPI and a co-author of the new study. “Artemisia can be grown readily in most climates,” she says. “It is a relatively simple process to harvest the leaves, pulverize them, test samples for their potency, measure out doses, and put them in capsules. This could become the basis for local businesses and be a wonderful socioeconomic stimulus in developing countries.”

    Weathers has been studying the antimalarial abilities of Artemisia annua for more than two decades. She first described the efficacy of using of the whole plant as an antimalarial treatment in a 2011 paper published inPhotochemistry Reviews. In the latest study, a high-yield cultivar of the plant developed in her lab was administered to mice by her team, led by Stephen Rich, a molecular parasitologist at the University of Massachusetts Amherst. The effects of the whole plant therapy were compared to the effects of comparable doses of pure artemisinin.

    The researchers found that mice receiving a dose of the dried leaves containing a low level of artemisinin showed a significantly greater reduction in blood-borne parasites over the course of 12 to 72 hours than mice receiving the same dose of the pure artemisinin drug. When plant material containing a high level of artemisinin was given to mice, the whole plant was as effective as a high dose of the drug in clearing parasites from the blood. Interestingly, plant material with a low level of artemisinin was as effective in killing parasites as a high dose of the drug, although its effects seemed to wane after 72 hours, suggesting that multiple doses would be necessary to fully treat a malarial infection.

    Weathers says the effectiveness of the whole plant treatment seems to be due, in part, to the fact that artemisinin from the dried leaves enters the bloodstream far more readily than the pure drug. “In our 2011 study, we showed that it takes about 40 times less artemisinin to achieve a comparable blood serum level when the compound is administered in the form of the whole plant,” she says. “This is consistent with the results of earlier studies in which people consumed teas made from whole leaves fromArtemisia annua.”

    Weathers says the effectiveness of using the whole plant as a therapy is likely a product of the plant’s complex biochemistry. “The leaves of Artemisiacontain a host of compounds that are of interest for their apparent but lesser antimalarial abilities,” she says. “These include at least six flavonoids that have been shown to work synergistically with artemisinin to kill malaria parasites. This makes the artemisia leaves a combination therapy all by themselves. In fact, we have referred to the whole plant as pACT (plant Artemisinin Combination Therapy), to distinguish it from the Artemisinin Combination Therapies (ACT) that are now recommended for malaria treatment by the World Health Organization.

    Artemisia annua is classified as a “generally regarded as safe” (GRAS) herb that has been consumed by humans and used as an herbal therapy for thousands of years. Weathers says she has been actively working for several years to establish the foundation for a new model for using whole plant therapy to combat malaria. She said she envisions local operations where farmers would grow the high-producing cultivars of Artemisia she and others have developed as a supplemental crop and deliver the leaves to processing stations, where they would be dried, pulverized, and homogenized, and where the powder would be placed in capsules or compacted into tablets.

    “By decentralizing the production of pACT, and giving local farmers and business people the opportunity to earn a living from producing it, we will not only make an effective therapy broadly available at an affordable price, we will help stimulate the economies of developing nations. It is exciting to be involved with a project that can be beneficial in so many ways.

    “When you consider that artemisinin and some of the flavonoids in Artemisia annua have been to have a therapeutic effect against host of other diseases, including Leishmania, schistosomiasis, and other ailments that are serious health hazards in the developing world, the long-term possibilities of this research grow exponentially.”

    Related Posts

    • Study is first to explain type of antimalarial drug resistanceStudy is first to explain type of antimalarial drug resistance
    • ‘Self-sabotage’ prevents immune protection against malaria‘Self-sabotage’ prevents immune protection against malaria
    • Africa: Technology Roadmap Resets Targets On Malaria VaccinesAfrica: Technology Roadmap Resets Targets On Malaria Vaccines
    • Kenya: Solar Mosquito Trap May Cut MalariaKenya: Solar Mosquito Trap May Cut Malaria
    • Malaria vaccines: The long warMalaria vaccines: The long war
    • Benin: Scientists Unveil Enhanced Malaria Test
    Sovrn
    Share

    Categories: Health, Science

    Tags: Artemisia annua, artemisinin, Malaria, whole plant therapy, Worcester Polytechnic

    soleRebels Footwear How Entrepreneurs Think: Why Effectuation and Effectual Logic May be the Key to Successful Enterprise Entrepreneurship

    Leave a Reply Cancel reply

    You must be logged in to post a comment.

Subscribe to our stories


 

Recent Posts

  • SL Crowd Green Solutions September 21, 2020
  • Digital transformation in the banking sector: surveys exploration and analytics August 3, 2020
  • Why Let Others Disrupt You? Take the Smart Self-Disruption Journey! August 3, 2020
  • 5 Tips for Crowdfunding During the Pandemic August 3, 2020
  • innovation + africa; +639 new citations August 3, 2020

Categories

Archives

Popular Post-All time

  • A review on biomass-based... 0.9k views
  • Can blockchain disrupt ge... 683 views
  • Prize-winning projects pr... 678 views
  • Apply Now: $500,000 for Y... 605 views
  • Test Your Value Propositi... 533 views

Recent Posts

  • SL Crowd Green Solutions
  • Digital transformation in the banking sector: surveys exploration and analytics
  • Why Let Others Disrupt You? Take the Smart Self-Disruption Journey!
  • 5 Tips for Crowdfunding During the Pandemic
  • innovation + africa; +639 new citations
  • SME Innovation: 10 Priorities for Support Post-COVID-19 
  • Africa RISING Annual Progress Report 2018 – 2019 now available
  • Fodder beet feed supplementation delivers dairy success for Ethiopian farmers
  • Using theory of change for outcome-oriented research
  • Africa RISING partners publish soil fertility management guidebook

Tag Cloud

    africa African Agriculture Business Business model Business_Finance Company Crowdsourcing data Development East Africa economics Education Entrepreneur entrepreneurs Entrepreneurship ethiopia ghana Health_Medical_Pharma ict Information technology Innovation kenya knowledge Knowledge Management Leadership marketing mobile Mobile phone nigeria Open innovation Organization Research rwanda science Science and technology studies social enterprise social entrepreneurship south africa Strategic management strategy tanzania Technology Technology_Internet uganda

Categories

Archives

  • A review on biomass-based hydrogen production for renewable energy supply 0.9k views
  • Can blockchain disrupt gender inequality? 683 views
  • Prize-winning projects promote healthier eating, smarter crop investments 678 views
  • Apply Now: $500,000 for Your Big Data Innovations in Agriculture 605 views
  • Test Your Value Proposition: Supercharge Lean Startup and CustDev Principles 533 views

Copyright © 2005-2020 Innovation Africa Theme created by PWT. Powered by WordPress.org